The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Jun. 23, 2022
Applicant:
Tempest Therapeutics, Inc., Brisbane, CA (US);
Inventors:
Yalda Bravo, San Diego, CA (US);
Austin Chih-Yu Chen, San Marcos, CA (US);
Jinyue Ding, Burnaby, CA;
Robert Gomez, North Vancouver, CA;
Heather Lam, Scarborough, CA;
Joe Fred Nagamizo, San Diego, CA (US);
Renata Marcella Oballa, Coquitlam, CA;
David Andrew Powell, Vancouver, CA;
Tao Sheng, Coquitlam, CA;
Assignee:
TEMPEST THERAPEUTICS, INC., Brisbane, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/56 (2006.01); C07D 401/10 (2006.01); C07D 209/42 (2006.01); C07D 405/12 (2006.01); C07D 471/04 (2006.01); C07D 403/10 (2006.01); C07D 417/10 (2006.01);
U.S. Cl.
CPC ...
C07D 401/10 (2013.01); C07D 209/42 (2013.01); C07D 231/56 (2013.01); C07D 403/10 (2013.01); C07D 405/12 (2013.01); C07D 417/10 (2013.01); C07D 471/04 (2013.01);
Abstract
Compounds, compositions and methods are provided for modulating the activity of EPand EPreceptors, and for the treatment, prevention and amelioration of one or more symptoms of diseases or disorders related to the activity of EPand EPreceptors. In certain embodiments, the compounds are antagonists of both the EPand EPreceptors.